Phenotypic changes on M.tb-specific CD4 T cells are also used as surrogate markers for TB treatment efficacy and can help to discriminate between TB (profile: CD38pos, CD27low), treated TB (CD38neg, CD27low), and LTBI (CD38neg, CD27high) (89). The gene discussed is CD4; the disease is tuberculosis.